Drugs / WX-UK1
last change May 2004 re-read 2 minutes ago

WX-UK1

Developed for
cancer
Investigated by
Heidelberg Pharma AG · United States Department of Defense

Trials 1 · a red edge is where a trial was stopped

200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00083525 May 2004 → ? cancer Heidelberg Pharma AG Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as WX-UK1 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00083525